Eiman Jahangir

17.3k total citations · 2 hit papers
40 papers, 1.8k citations indexed

About

Eiman Jahangir is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eiman Jahangir has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Eiman Jahangir's work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Eiman Jahangir is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Eiman Jahangir collaborates with scholars based in United States, Australia and Argentina. Eiman Jahangir's co-authors include Carl J. Lavie, Alban De Schutter, Adolfo Rubinstein, Andrea Beratarrechea, Jonathan Willner, Agustín Ciapponi, Parham Parto, Ross Arena, Richard V. Milani and Francisco B. Ortega and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Eiman Jahangir

38 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and Prevalence of Cardiovascular Diseases and Prognosis—The Obesity Paradox Updated

2016 337 citations Carl J. Lavie, Alban De Schutter et al. Progress in Cardiovascular Diseases profile →
The Impact of Mobile Health Interventions on Chronic Disease Outcomes in Developing Countries: A Systematic Review

2013 287 citations Andrea Beratarrechea, Jonathan Willner et al. Telemedicine Journal and e-Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eiman Jahangir United States	19	821	320	306	266	239	40	1.8k
Julie George United States	19	1.3k 1.5×	162 0.5×	276 0.9×	330 1.2×	216 0.9×	54	2.5k
Mónica Acevedo Chile	20	889 1.1×	163 0.5×	232 0.8×	366 1.4×	143 0.6×	85	1.8k
Nicholas Jones United Kingdom	24	1.0k 1.2×	136 0.4×	168 0.5×	198 0.7×	264 1.1×	74	2.4k
Jon-David Schwalm Canada	20	1.0k 1.2×	137 0.4×	336 1.1×	281 1.1×	121 0.5×	67	2.3k
Rebecca S. Boxer United States	26	799 1.0×	482 1.5×	570 1.9×	237 0.9×	152 0.6×	84	2.5k
Joel B. Braunstein United States	24	1.0k 1.3×	530 1.7×	226 0.7×	283 1.1×	203 0.8×	67	2.7k
Georgios Lappas Sweden	26	847 1.0×	383 1.2×	138 0.5×	498 1.9×	248 1.0×	92	2.4k
Ambuj Roy India	23	1.0k 1.2×	117 0.4×	217 0.7×	247 0.9×	108 0.5×	147	2.1k
Luigi Palmieri Italy	24	726 0.9×	170 0.5×	182 0.6×	536 2.0×	133 0.6×	157	2.0k

Countries citing papers authored by Eiman Jahangir

Since Specialization

Citations

This map shows the geographic impact of Eiman Jahangir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiman Jahangir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiman Jahangir more than expected).

Fields of papers citing papers by Eiman Jahangir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiman Jahangir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiman Jahangir. The network helps show where Eiman Jahangir may publish in the future.

Co-authorship network of co-authors of Eiman Jahangir

This figure shows the co-authorship network connecting the top 25 collaborators of Eiman Jahangir. A scholar is included among the top collaborators of Eiman Jahangir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiman Jahangir. Eiman Jahangir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleming, Matthew R., Tao Yang, John M. Wells, et al.. (2025). PO-05-028 THE TYROSINE KINASE INHIBITOR ENTRECTINIB RESULTS IN VENTRICULAR TACHYCARDIA AND BRUGADA PHENOCOPY THROUGH INHIBITION OF SODIUM CURRENT. Heart Rhythm. 22(4). S574–S574. 1 indexed citations

Morgans, Amee, et al.. (2024). Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease. Southern Medical Journal. 117(5). 245–253.

Jahangir, Eiman, Karl M. Kochendorfer, Michal Laufer‐Perl, et al.. (2023). Artificial intelligence modelling to assess the risk of cardiovascular disease in oncology patients. European Heart Journal - Digital Health. 4(4). 302–315. 10 indexed citations

Takahashi, Edwin A., Lee H. Schwamm, Opeolu Adeoye, et al.. (2022). An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 146(25). e558–e568. 70 indexed citations

Aponte, Maria, Peter Kim, Anita Deswal, et al.. (2020). Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. SHILAP Revista de lepidopterología. 3(3). 113–120. 12 indexed citations

Mahapatra, Somnath, Dhrubajyoti Bandyopadhyay, Santanu Samanta, et al.. (2020). Bleeding with vascular endothelial growth factor tyrosine kinase inhibitor: A network meta-analysis. Critical Reviews in Oncology/Hematology. 157. 103186–103186. 22 indexed citations

Tuzovic, Mirela, Sherry‐Ann Brown, Eric H. Yang, et al.. (2020). Implementation of Cardio-Oncology Training for Cardiology Fellows. JACC CardioOncology. 2(5). 795–799. 7 indexed citations

Oktay, Ahmet, Halis Kaan Aktürk, & Eiman Jahangir. (2016). Diabetes mellitus and hypertension. Current Opinion in Cardiology. 31(4). 402–409. 40 indexed citations

Parto, Parham, et al.. (2016). Cardiovascular Risk and Level of Statin Use Among Women With Breast Cancer in a Cardio-Oncology Clinic.. PubMed. 16(3). 217–24. 10 indexed citations

10.

Abdalla, Marwah, Connie Liu, Julie B. Damp, et al.. (2016). The Importance of Global Health Experiences in the Development of New Cardiologists. Journal of the American College of Cardiology. 67(23). 2789–2797. 5 indexed citations

11.

Lavie, Carl J., Alban De Schutter, Parham Parto, et al.. (2016). Obesity and Prevalence of Cardiovascular Diseases and Prognosis—The Obesity Paradox Updated. Progress in Cardiovascular Diseases. 58(5). 537–547. 337 indexed citations breakdown →

12.

Domerçant, Jean Wysler, et al.. (2016). Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.. PubMed. 16(3). 250–6. 20 indexed citations

13.

Bober, Robert & Eiman Jahangir. (2015). What Is Ischemia and How Should This Be Defined Based on Modern Imaging?. Progress in Cardiovascular Diseases. 57(6). 537–554. 8 indexed citations

14.

Jahangir, Eiman, et al.. (2015). Risk Assessment and Management of Anthracycline and HER2 Receptor Inhibitor–Induced Cardiomyopathy. Southern Medical Journal. 108(2). 71–78. 1 indexed citations

15.

Morris, Pamela B., Brian A. Ference, Eiman Jahangir, et al.. (2015). Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes. Journal of the American College of Cardiology. 66(12). 1378–1391. 160 indexed citations

16.

Jahangir, Eiman, Alban De Schutter, & Carl J. Lavie. (2014). Low Weight and Overweightness in Older Adults: Risk and Clinical Management. Progress in Cardiovascular Diseases. 57(2). 127–133. 56 indexed citations

17.

Beratarrechea, Andrea, et al.. (2013). The Impact of Mobile Health Interventions on Chronic Disease Outcomes in Developing Countries: A Systematic Review. Telemedicine Journal and e-Health. 20(1). 75–82. 287 indexed citations breakdown →

18.

Jahangir, Eiman, Vilma Irazola, & Adolfo Rubinstein. (2012). Need, Enabling, Predisposing, and Behavioral Determinants of Access to Preventative Care in Argentina: Analysis of the National Survey of Risk Factors. PLoS ONE. 7(9). e45053–e45053. 54 indexed citations

19.

Jahangir, Eiman. (2011). Cardiovascular disease research in Latin America: A comparative bibliometric analysis. World Journal of Cardiology. 3(12). 383–383. 23 indexed citations

20.

Delaney, Jessica, Andrea H. Ramirez, Erica Bowton, et al.. (2011). Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record. Clinical Pharmacology & Therapeutics. 91(2). 257–263. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact